hwa 138 has been researched along with torbafylline in 8 studies
Studies (hwa 138) | Trials (hwa 138) | Recent Studies (post-2010) (hwa 138) | Studies (torbafylline) | Trials (torbafylline) | Recent Studies (post-2010) (torbafylline) |
---|---|---|---|---|---|
22 | 0 | 0 | 32 | 1 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmid-Schönbein, GW; Wong, PM | 1 |
Berens, KL; Langston, JD; Luke, DR; Wasan, KM | 1 |
Schade, UF | 1 |
Hand, DL; Hand, WL | 1 |
Lagarde, M; Meskini, N; Némoz, G; Okyayuz-Baklouti, I; Prigent, AF | 1 |
Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J | 1 |
Bendtzen, K; Jakobsen, PH; Koch, C | 1 |
Kelleher, DK; Thews, O; Vaupel, P | 1 |
8 other study(ies) available for hwa 138 and torbafylline
Article | Year |
---|---|
Attenuation of spontaneous pseudopod formation in human neutrophils by pentoxifylline.
Topics: Actins; Adult; Complement C5a; Cytoplasm; Dose-Response Relationship, Drug; Endotoxins; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Pseudopodia; Receptors, Purinergic; Theophylline; Time Factors | 1991 |
Influence of pentoxifylline and related analogues in endotoxemic renal failure.
Topics: Acute Kidney Injury; Animals; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Kidney; Male; Pentoxifylline; Rats; Rats, Inbred Strains | 1991 |
The role of prostacyclin in the protective effects of pentoxifylline and other xanthine derivatives in endotoxin action in mice.
Topics: Animals; Endotoxins; Epoprostenol; Female; Indomethacin; Leukopenia; Lipopolysaccharides; Mice; Pentoxifylline; Theobromine; Tumor Necrosis Factor-alpha | 1989 |
Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Cells, Cultured; Clindamycin; Drug Interactions; Erythromycin; Humans; Macrolides; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Phagocytosis; Respiratory Burst; Roxithromycin; Superoxides | 1995 |
Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation.
Topics: Animals; Heart Ventricles; Isoenzymes; Male; Microcirculation; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Xanthines | 1994 |
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1993 |
Inhibition of LPS and Plasmodium falciparum induced cytokine secretion by pentoxifylline and two analogues.
Topics: Adult; Animals; Cytokines; Female; Humans; In Vitro Techniques; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Pentoxifylline; Phosphodiesterase Inhibitors; Plasmodium falciparum; Tumor Necrosis Factor-alpha | 1997 |
Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration.
Topics: Animals; Male; Neoplasms, Experimental; Oxygen Consumption; Pentoxifylline; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sarcoma, Experimental; Vasodilator Agents | 1998 |